People · Operator
Named in public records as an officer, director or promoter · active 2012–2014 · Other Health Care, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VytronUS Inc | — | Other Health Care | Series B | $91.1M | $664.6M | 2012 |
| Advanced Cardiac Therapeutics Inc | — | Pharma | Series C | $64.1M | $1.6B | 2014 |
Michael Pederson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Pederson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Roy Tanaka | 2 | 6 |
| Ryan Drant | 1 | 24 |
| John Nehra | 1 | 11 |
| Duke Rohlen | 1 | 10 |
| Doug Koo | 1 | 8 |
| Peter Justin Klein | 1 | 7 |
| Justin Klein | 1 | 6 |
| Michael Henson | 1 | 5 |
| John Pavlidis | 1 | 4 |
| Peter Van Der Sluis | 1 | 3 |
| John Maroney | 1 | 3 |
| A. Jay Graf | 1 | 3 |
| William Olson | 1 | 3 |
| Eric Kanowsky | 1 | 2 |
| Aris Constantinides | 1 | 2 |
| David Jay McIntyre | 1 | 1 |
| Sami Jay Hamade | 1 | 1 |
| Hank Jay Kucheman | 1 | 1 |
| Philippe Marco | 1 | 1 |
| David Gallup | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.